Inactive Instrument

Press Releases Innovate Biopharmaceuticals Inc Nasdaq

Equities

US61174L5012

Press Releases

Unlock all the news: Be the first to know and act before the market!

Celiac Disease Pipeline, Clinical Trials, FDA Approvals, and Emerging Drugs 2023 (Updated)	23-10-02	AQ
9 METERS BIOPHARMA, INC. : Change in Directors or Principal Officers (form 8-K)	23-05-30	AQ
9 METERS BIOPHARMA, INC. : Other Events (form 8-K)	23-05-22	AQ
9 METERS BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Financial Statements and Exhibits (form 8-K)	23-04-27	AQ
9 METERS BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	23-04-06	AQ
9 METERS BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	23-04-05	AQ
9 METERS BIOPHARMA, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-03-28	AQ
9 METERS BIOPHARMA, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-03-28	AQ
9 METERS BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	23-03-15	AQ
9 METERS BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	23-03-13	AQ
9 METERS BIOPHARMA, INC. : Other Events (form 8-K)	23-03-13	AQ
9 METERS BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23-01-13	AQ
9 Meters Biopharma Announces Phase 3 Study of Vurolenatide in Short Bowel Syndrome	22-11-30	AQ
9 METERS BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	22-11-29	AQ
9 METERS BIOPHARMA, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-11-08	AQ
9 METERS BIOPHARMA, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	22-11-08	AQ
9 METERS BIOPHARMA, INC. : Other Events (form 8-K)	22-11-01	AQ
9 METERS BIOPHARMA, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-10-21	AQ
9 METERS BIOPHARMA, INC. : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (form 8-K)	22-10-17	AQ
9 METERS BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	22-10-06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Innovate Biopharmaceuticals Inc Nasdaq

Equities

US61174L5012

Press Releases

Filters